{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:21:07Z","timestamp":1788394867149,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,7]]},"DOI":"10.7759\/cureus.50116","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T15:23:48Z","timestamp":1701962628000},"source":"Crossref","is-referenced-by-count":1,"title":["The Role of Low-Dose Quetiapine in the Treatment of Somatic Symptom Disorder: A Case Report"],"prefix":"10.7759","author":[{"given":"Shayranisse","family":"Pagan Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M","family":"Guiribitey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger","family":"Shupe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"Somatic symptoms and related disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Somatic symptoms and related disorders. Diagnostic and statistical manual of mental disorders: DSM-5\u2122, 5th ed.. American Psychiatric Association, Arlington, VA; 2013. 309-15. 10.1176\/appi.books.9780890425596"},{"key":"ref2","article-title":"","author":"D'Souza RS","year":"2023","unstructured":"D'Souza RS, Hooten WM. Somatic symptom disorder. StatPearls Publishing, Treasure Island (FL); 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532253."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.etdah.2022.100031","article-title":"Brexpiprazole as a new approach of treatment in somatization disorder","volume":"2","author":"Chiappini S","year":"2022","unstructured":"Chiappini S, Mosca A, Martinotti G, et al.. Brexpiprazole as a new approach of treatment in somatization disorder. Emerging Trends in Drugs, Addictions, and Health. 2022, 2:100031. 10.1016\/j.etdah.2022.100031","journal-title":"Emerging Trends in Drugs, Addictions, and Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1017\/9781009053365","article-title":"Antipsychotic agents","author":"Stahl SM","year":"2022","unstructured":"Stahl SM, Grady MM, Muntner N. Antipsychotic agents. Stahl's essential psychopharmacology: neuroscientific basis and practical applications. Cambridge University Press, 2022. 159-243. 10.1017\/9781009053365"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2023.21.1.49","article-title":"Quetiapine treatment for post-traumatic stress disorder: a systematic review of the literature","volume":"21","author":"Crapanzano C","year":"2023","unstructured":"Crapanzano C, Damiani S, Casolaro I, Amendola C. Quetiapine treatment for post-traumatic stress disorder: a systematic review of the literature. Clin Psychopharmacol Neurosci. 2023, 21:49-56. 10.9758\/cpn.2023.21.1.49","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0000000000001052","article-title":"Olanzapine for the treatment of somatic symptom disorder: biobehavioral Processes and clinical implications","volume":"84","author":"Crapanzano C","year":"2022","unstructured":"Crapanzano C, Amendola C, Politano A, Laurenzi PF, Casolaro I. Olanzapine for the treatment of somatic symptom disorder: biobehavioral Processes and clinical implications. Psychosom Med. 2022, 84:393-5. 10.1097\/PSY.0000000000001052","journal-title":"Psychosom Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e00688","article-title":"Patterns of benzodiazepines use in primary care adults with anxiety disorders","volume":"4","author":"Tanguay Bernard MM","year":"2018","unstructured":"Tanguay Bernard MM, Luc M, Carrier JD, et al.. Patterns of benzodiazepines use in primary care adults with anxiety disorders. Heliyon. 2018, 4:e00688. 10.1016\/j.heliyon.2018.e00688","journal-title":"Heliyon"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2020.09.636","article-title":"Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study","volume":"41","author":"Dold M","year":"2020","unstructured":"Dold M, Bartova L, Fugger G, et al.. Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study. Eur Neuropsychopharmacol. 2020, 41:70-80. 10.1016\/j.euroneuro.2020.09.636","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00286","article-title":"Dysfunction in serotonergic and noradrenergic systems and somatic symptoms in psychiatric disorders","volume":"10","author":"Liu Y","year":"2019","unstructured":"Liu Y, Zhao J, Fan X, Guo W. Dysfunction in serotonergic and noradrenergic systems and somatic symptoms in psychiatric disorders. Front Psychiatry. 2019, 10:286. 10.3389\/fpsyt.2019.00286","journal-title":"Front Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.13070170","article-title":"A neural circuit framework for somatosensory amplification in somatoform disorders","volume":"27","author":"Perez DL","year":"2015","unstructured":"Perez DL, Barsky AJ, Vago DR, Baslet G, Silbersweig DA. A neural circuit framework for somatosensory amplification in somatoform disorders. J Neuropsychiatry Clin Neurosci. 2015, 27:e40-50. 10.1176\/appi.neuropsych.13070170","journal-title":"J Neuropsychiatry Clin Neurosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/196351-the-role-of-low-dose-quetiapine-in-the-treatment-of-somatic-symptom-disorder-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:28Z","timestamp":1707509308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/196351-the-role-of-low-dose-quetiapine-in-the-treatment-of-somatic-symptom-disorder-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.50116","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,7]]}}}